help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 11, 2004
Endocrinology, doi:10.1210/en.2004-1186
A more recent version of this article appeared on February 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
146/2/694    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramos, M. P.
Right arrow Articles by Gonzalez, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramos, M. P.
Right arrow Articles by Gonzalez, R. R.

Submitted on September 3, 2004
Accepted on October 28, 2004

Leptin serves as an upstream activator of an obligatory signaling cascade in the embryo-implantation process

M. P. Ramos, B. R. Rueda, P. C. Leavis, and R. R. Gonzalez*

Boston Biomedical Research Institute (BBRI), 64 Grove St., Watertown, MA 02472; Vincent Center for Reproductive Biology, Massachusetts General Hospital, Boston, MA 02114; Harvard Medical School, Boston, MA 02115; Dept of Physiology, Tufts University School of Medicine, Boston, MA 02111

* To whom correspondence should be addressed. E-mail: gonzalezr{at}bbri.org.

Leptin is essential for mouse reproduction but the exact roles it serves are yet to be determined. Treatment of cultured endometrial cells with leptin increases the level of {beta}3-integrin, interleukin-1 (IL-1), leukemia inhibitory factor (LIF) and their corresponding receptors. These leptin-induced effects are eliminated by inhibitors of leptin receptor (OB-R) signaling. Herein the impact of blocking leptin/OB-R signaling in the mouse endometrium was assessed. Intra-uterine injection of either leptin peptide antagonists (LPA-1 or -2) or OB-R antibody on day 3 of pregnancy impaired mouse implantation in comparison to intra-uterine injection of scrambled peptides (LPA-Sc) or species-matched IgGs. Significant reduction in the number of implantation sites and uterine horns with implanted embryos was found after intra-uterine injection of LPA-1 (1/22) vs. LPA-1Sc (11/15) and LPA-2 (3/17) vs. LPA-2Sc (14/16). The impact of disruption of leptin signaling on the endometrial expression of several molecules in pregnant mice was assessed by Western blot, immunohistochemistry and confocal microscopy. Disruption of leptin signaling resulted in a significant reduction of IL-1 receptor type I (IL-1R tI), LIF-receptor (LIF-R), vascular endothelial growth factor receptor 2 (VEGF-R2/flk-1) and {beta}3-integrin levels. The levels of colony stimulating factor-1 receptor (CSF-1R) and OB-R were unaltered after treatment with LPAs compared with controls. Expression of OB-R protein was pregnancy-dependent and only found in glandular epithelium after implantation occurred. Our findings support previous observations that leptin signaling is critical to the implantation process and suggest that molecules downstream of leptin-activated receptor may serve obligatory roles in endometrial receptivity and successful implantation.


Key words: Leptin signaling • leptin peptide antagonists • implantation • endometrium • cytokines • {beta}3 integrin • uterine embryo interaction




This article has been cited by other articles:


Home page
EndocrinologyHome page
A. K. Styer, B. T. Sullivan, M. Puder, D. Arsenault, J. C. Petrozza, T. Serikawa, S. Chang, T. Hasan, R. R. Gonzalez, and B. R. Rueda
Ablation of Leptin Signaling Disrupts the Establishment, Development, and Maintenance of Endometriosis-Like Lesions in a Murine Model
Endocrinology, February 1, 2008; 149(2): 506 - 514.
[Abstract] [Full Text] [PDF]


Home page
J DAIRY SCIHome page
S. R. Thorn, M. J. Meyer, M. E. Van Amburgh, and Y. R. Boisclair
Effect of Estrogen on Leptin and Expression of Leptin Receptor Transcripts in Prepubertal Dairy Heifers
J Dairy Sci, August 1, 2007; 90(8): 3742 - 3750.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. R. Gonzalez, S. Cherfils, M. Escobar, J. H. Yoo, C. Carino, A. K. Styer, B. T. Sullivan, H. Sakamoto, A. Olawaiye, T. Serikawa, et al.
Leptin Signaling Promotes the Growth of Mammary Tumors and Increases the Expression of Vascular Endothelial Growth Factor (VEGF) and Its Receptor Type Two (VEGF-R2)
J. Biol. Chem., September 8, 2006; 281(36): 26320 - 26328.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. C. Henson and V. D. Castracane
Leptin in Pregnancy: An Update
Biol Reprod, February 1, 2006; 74(2): 218 - 229.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society